Global Hormone Replacement Therapy Market Insights and Forecast to 2034
Hormone Replacement Therapy market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Hormone Replacement Therapy market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2016-2027.
Segment by Type
Estrogen Hormone
Growth Hormone
Thyroid Hormone
Testosterone Hormone
The proportion of estrogen hormone in 2018 is about 50%, and the proportion is in increasing trend from 2014 to 2018.
Segment by Application
Menopause
Hypothyroidism
Growth Hormone Deficiency
Male Hypogonadism
Other Diseases
The most proportion of hormone replacement therapy is used in menopause, and the proportion in 2018 is 46.2%.
By Company
Eli Lilly
Pfizer
AbbVie
Novo Nordisk
Merck KGaA
Mylan
Bayer
Teva
Novartis
Abbott
Roche
Endo International
Ipsen
ANI Pharmaceuticals
TherapeuticsMD
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
Table of Content
1 Study Coverage
1.1 Hormone Replacement Therapy Product Introduction
1.2 Market by Type
1.2.1 Global Hormone Replacement Therapy Market Size Growth Rate by Type
1.4.2 Estrogen Hormone
1.4.3 Growth Hormone
1.2.4 Thyroid Hormone
1.2.5 Testosterone Hormone
1.3 Market by Application
1.3.1 Global Hormone Replacement Therapy Market Size Growth Rate by Application
1.3.2 Menopause
1.3.3 Hypothyroidism
1.3.4 Growth Hormone Deficiency
1.3.5 Male Hypogonadism
1.3.6 Other Diseases
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Hormone Replacement Therapy Sales Estimates and Forecasts 2016-2027
2.2 Global Hormone Replacement Therapy Revenue Estimates and Forecasts 2016-2027
2.3 Global Hormone Replacement Therapy Revenue by Region: 2016 VS 2021 VS 2027
2.4 Global Top Hormone Replacement Therapy Regions by Sales
2.4.1 Global Top Hormone Replacement Therapy Regions by Sales (2016-2021)
2.4.2 Global Top Hormone Replacement Therapy Regions by Sales (2022-2027)
2.5 Global Top Hormone Replacement Therapy Regions by Revenue
2.5.1 Global Top Hormone Replacement Therapy Regions by Revenue (2016-2021)
2.5.2 Global Top Hormone Replacement Therapy Regions by Revenue (2022-2027)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Hormone Replacement Therapy Sales by Manufacturers
3.1.1 Global Top Hormone Replacement Therapy Manufacturers by Sales (2016-2021)
3.1.2 Global Top Hormone Replacement Therapy Manufacturers Market Share by Sales (2016-2021)
3.1.3 Global Top 10 and Top 5 Companies by Hormone Replacement Therapy Sales in 2020
3.2 Global Hormone Replacement Therapy Revenue by Manufacturers
3.2.1 Global Top Hormone Replacement Therapy Manufacturers by Revenue (2016-2021)
3.2.2 Global Top Hormone Replacement Therapy Manufacturers Market Share by Revenue (2016-2021)
3.2.3 Global Top 10 and Top 5 Companies by Hormone Replacement Therapy Revenue in 2020
3.3 Global Hormone Replacement Therapy Sales Price by Manufacturers
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Hormone Replacement Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Hormone Replacement Therapy Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Hormone Replacement Therapy Sales by Type
4.1.1 Global Hormone Replacement Therapy Historical Sales by Type (2016-2021)
4.1.2 Global Hormone Replacement Therapy Forecasted Sales by Type (2022-2027)
4.1.3 Global Hormone Replacement Therapy Sales Market Share by Type (2016-2027)
4.2 Global Hormone Replacement Therapy Revenue by Type
4.2.1 Global Hormone Replacement Therapy Historical Revenue by Type (2016-2021)
4.2.2 Global Hormone Replacement Therapy Forecasted Revenue by Type (2022-2027)
4.2.3 Global Hormone Replacement Therapy Revenue Market Share by Type (2016-2027)
4.3 Global Hormone Replacement Therapy Price by Type
4.3.1 Global Hormone Replacement Therapy Price by Type (2016-2021)
4.3.2 Global Hormone Replacement Therapy Price Forecast by Type (2022-2027)
5 Market Size by Application
5.1 Global Hormone Replacement Therapy Sales by Application
5.1.1 Global Hormone Replacement Therapy Historical Sales by Application (2016-2021)
5.1.2 Global Hormone Replacement Therapy Forecasted Sales by Application (2022-2027)
5.1.3 Global Hormone Replacement Therapy Sales Market Share by Application (2016-2027)
5.2 Global Hormone Replacement Therapy Revenue by Application
5.2.1 Global Hormone Replacement Therapy Historical Revenue by Application (2016-2021)
5.2.2 Global Hormone Replacement Therapy Forecasted Revenue by Application (2022-2027)
5.2.3 Global Hormone Replacement Therapy Revenue Market Share by Application (2016-2027)
5.3 Global Hormone Replacement Therapy Price by Application
5.3.1 Global Hormone Replacement Therapy Price by Application (2016-2021)
5.3.2 Global Hormone Replacement Therapy Price Forecast by Application (2022-2027)
6 North America
6.1 North America Hormone Replacement Therapy Market Size by Type
6.1.1 North America Hormone Replacement Therapy Sales by Type (2016-2027)
6.1.2 North America Hormone Replacement Therapy Revenue by Type (2016-2027)
6.2 North America Hormone Replacement Therapy Market Size by Application
6.2.1 North America Hormone Replacement Therapy Sales by Application (2016-2027)
6.2.2 North America Hormone Replacement Therapy Revenue by Application (2016-2027)
6.3 North America Hormone Replacement Therapy Market Size by Country
6.3.1 North America Hormone Replacement Therapy Sales by Country (2016-2027)
6.3.2 North America Hormone Replacement Therapy Revenue by Country (2016-2027)
6.3.3 U.S.
6.3.4 Canada
7 Europe
7.1 Europe Hormone Replacement Therapy Market Size by Type
7.1.1 Europe Hormone Replacement Therapy Sales by Type (2017-2027)
7.1.2 Europe Hormone Replacement Therapy Revenue by Type (2017-2027)
7.2 Europe Hormone Replacement Therapy Market Size by Application
7.2.1 Europe Hormone Replacement Therapy Sales by Application (2017-2027)
7.2.2 Europe Hormone Replacement Therapy Revenue by Application (2017-2027)
7.3 Europe Hormone Replacement Therapy Market Size by Country
7.3.1 Europe Hormone Replacement Therapy Sales by Country (2017-2027)
7.3.2 Europe Hormone Replacement Therapy Revenue by Country (2017-2027)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Hormone Replacement Therapy Market Size by Type
8.1.1 Asia Pacific Hormone Replacement Therapy Sales by Type (2018-2027)
8.1.2 Asia Pacific Hormone Replacement Therapy Revenue by Type (2018-2027)
8.2 Asia Pacific Hormone Replacement Therapy Market Size by Application
8.2.1 Asia Pacific Hormone Replacement Therapy Sales by Application (2018-2027)
8.2.2 Asia Pacific Hormone Replacement Therapy Revenue by Application (2018-2027)
8.3 Asia Pacific Hormone Replacement Therapy Market Size by Region
8.3.1 Asia Pacific Hormone Replacement Therapy Sales by Region (2018-2027)
8.3.2 Asia Pacific Hormone Replacement Therapy Revenue by Region (2018-2027)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
8.3.12 Philippines
9 Latin America
9.1 Latin America Hormone Replacement Therapy Market Size by Type
9.1.1 Latin America Hormone Replacement Therapy Sales by Type (2019-2027)
9.1.2 Latin America Hormone Replacement Therapy Revenue by Type (2019-2027)
9.2 Latin America Hormone Replacement Therapy Market Size by Application
9.2.1 Latin America Hormone Replacement Therapy Sales by Application (2019-2027)
9.2.2 Latin America Hormone Replacement Therapy Revenue by Application (2019-2027)
9.3 Latin America Hormone Replacement Therapy Market Size by Country
9.3.1 Latin America Hormone Replacement Therapy Sales by Country (2019-2027)
9.3.2 Latin America Hormone Replacement Therapy Revenue by Country (2019-2027)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
6 Middle East and Africa
6.1 Middle East and Africa Hormone Replacement Therapy Market Size by Type
6.1.1 Middle East and Africa Hormone Replacement Therapy Sales by Type (2016-2027)
6.1.2 Middle East and Africa Hormone Replacement Therapy Revenue by Type (2016-2027)
6.2 Middle East and Africa Hormone Replacement Therapy Market Size by Application
6.2.1 Middle East and Africa Hormone Replacement Therapy Sales by Application (2016-2027)
6.2.2 Middle East and Africa Hormone Replacement Therapy Revenue by Application (2016-2027)
6.3 Middle East and Africa Hormone Replacement Therapy Market Size by Country
6.3.1 Middle East and Africa Hormone Replacement Therapy Sales by Country (2016-2027)
6.3.2 Middle East and Africa Hormone Replacement Therapy Revenue by Country (2016-2027)
6.3.3 Turkey
6.3.4 Saudi Arabia
6.3.5 U.A.E
11 Company Profiles
11.1 Eli Lilly
11.1.1 Eli Lilly Corporation Information
11.1.2 Eli Lilly Overview
11.1.3 Eli Lilly Hormone Replacement Therapy Sales, Price, Revenue and Gross Margin (2016-2021)
11.1.4 Eli Lilly Hormone Replacement Therapy Product Description
11.1.5 Eli Lilly Related Developments
11.2 Pfizer
11.2.1 Pfizer Corporation Information
11.2.2 Pfizer Overview
11.2.3 Pfizer Hormone Replacement Therapy Sales, Price, Revenue and Gross Margin (2016-2021)
11.2.4 Pfizer Hormone Replacement Therapy Product Description
11.2.5 Pfizer Related Developments
11.3 AbbVie
11.3.1 AbbVie Corporation Information
11.3.2 AbbVie Overview
11.3.3 AbbVie Hormone Replacement Therapy Sales, Price, Revenue and Gross Margin (2016-2021)
11.3.4 AbbVie Hormone Replacement Therapy Product Description
11.3.5 AbbVie Related Developments
11.4 Novo Nordisk
11.4.1 Novo Nordisk Corporation Information
11.4.2 Novo Nordisk Overview
11.4.3 Novo Nordisk Hormone Replacement Therapy Sales, Price, Revenue and Gross Margin (2016-2021)
11.4.4 Novo Nordisk Hormone Replacement Therapy Product Description
11.4.5 Novo Nordisk Related Developments
11.5 Merck KGaA
11.5.1 Merck KGaA Corporation Information
11.5.2 Merck KGaA Overview
11.5.3 Merck KGaA Hormone Replacement Therapy Sales, Price, Revenue and Gross Margin (2016-2021)
11.5.4 Merck KGaA Hormone Replacement Therapy Product Description
11.5.5 Merck KGaA Related Developments
11.6 Mylan
11.6.1 Mylan Corporation Information
11.6.2 Mylan Overview
11.6.3 Mylan Hormone Replacement Therapy Sales, Price, Revenue and Gross Margin (2016-2021)
11.6.4 Mylan Hormone Replacement Therapy Product Description
11.6.5 Mylan Related Developments
11.7 Bayer
11.7.1 Bayer Corporation Information
11.7.2 Bayer Overview
11.7.3 Bayer Hormone Replacement Therapy Sales, Price, Revenue and Gross Margin (2016-2021)
11.7.4 Bayer Hormone Replacement Therapy Product Description
11.7.5 Bayer Related Developments
11.8 Teva
11.8.1 Teva Corporation Information
11.8.2 Teva Overview
11.8.3 Teva Hormone Replacement Therapy Sales, Price, Revenue and Gross Margin (2016-2021)
11.8.4 Teva Hormone Replacement Therapy Product Description
11.8.5 Teva Related Developments
11.9 Novartis
11.9.1 Novartis Corporation Information
11.9.2 Novartis Overview
11.9.3 Novartis Hormone Replacement Therapy Sales, Price, Revenue and Gross Margin (2016-2021)
11.9.4 Novartis Hormone Replacement Therapy Product Description
11.9.5 Novartis Related Developments
11.10 Abbott
11.10.1 Abbott Corporation Information
11.10.2 Abbott Overview
11.10.3 Abbott Hormone Replacement Therapy Sales, Price, Revenue and Gross Margin (2016-2021)
11.10.4 Abbott Hormone Replacement Therapy Product Description
11.10.5 Abbott Related Developments
11.1 Eli Lilly
11.1.1 Eli Lilly Corporation Information
11.1.2 Eli Lilly Overview
11.1.3 Eli Lilly Hormone Replacement Therapy Sales, Price, Revenue and Gross Margin (2016-2021)
11.1.4 Eli Lilly Hormone Replacement Therapy Product Description
11.1.5 Eli Lilly Related Developments
11.12 Endo International
11.12.1 Endo International Corporation Information
11.12.2 Endo International Overview
11.12.3 Endo International Hormone Replacement Therapy Sales, Price, Revenue and Gross Margin (2016-2021)
11.12.4 Endo International Product Description
11.12.5 Endo International Related Developments
11.13 Ipsen
11.13.1 Ipsen Corporation Information
11.13.2 Ipsen Overview
11.13.3 Ipsen Hormone Replacement Therapy Sales, Price, Revenue and Gross Margin (2016-2021)
11.13.4 Ipsen Product Description
11.13.5 Ipsen Related Developments
11.14 ANI Pharmaceuticals
11.14.1 ANI Pharmaceuticals Corporation Information
11.14.2 ANI Pharmaceuticals Overview
11.14.3 ANI Pharmaceuticals Hormone Replacement Therapy Sales, Price, Revenue and Gross Margin (2016-2021)
11.14.4 ANI Pharmaceuticals Product Description
11.14.5 ANI Pharmaceuticals Related Developments
11.15 TherapeuticsMD
11.15.1 TherapeuticsMD Corporation Information
11.15.2 TherapeuticsMD Overview
11.15.3 TherapeuticsMD Hormone Replacement Therapy Sales, Price, Revenue and Gross Margin (2016-2021)
11.15.4 TherapeuticsMD Product Description
11.15.5 TherapeuticsMD Related Developments
12 Value Chain and Sales Channels Analysis
12.1 Hormone Replacement Therapy Value Chain Analysis
12.2 Hormone Replacement Therapy Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Hormone Replacement Therapy Production Mode & Process
12.4 Hormone Replacement Therapy Sales and Marketing
12.4.1 Hormone Replacement Therapy Sales Channels
12.4.2 Hormone Replacement Therapy Distributors
12.5 Hormone Replacement Therapy Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Hormone Replacement Therapy Industry Trends
13.2 Hormone Replacement Therapy Market Drivers
13.3 Hormone Replacement Therapy Market Challenges
13.4 Hormone Replacement Therapy Market Restraints
14 Key Findings in The Global Hormone Replacement Therapy Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer